Purpose As part of the American Association of Physicists in Medicine Working Group on
Stereotactic Body Radiotherapy investigating normal tissue complication probability (NTCP) …

Background A combination of programmed cell death protein‐1 (PD‐1)/programmed cell
death ligand‐1 (PD‐L1) inhibitors and radiotherapy (RT) is increasingly being used to treat …

Background Although immunotherapy has been widely used, there is currently no research
comparing immunotherapy for non-small cell lung cancer (NSCLC) patients with brain …

Brain metastasis (BM), a devastating complication of advanced malignancy, has a high
incidence in non-small cell lung cancer (NSCLC). As novel systemic treatment drugs and …

Abstract Background: Immune checkpoint inhibitors (ICIs) are recommended to treat
advanced non-small cell lung cancer (NSCLC), whereas brain radiotherapy (RT) is the …

Background To define efficacy and toxicity of Immunotherapy (IT) with stereotactic
radiotherapy (SRT) including radiosurgery (RS) or hypofractionated SRT (HFSRT) for brain …

Background The purpose of this study was to compare the outcomes of patients with non-
small cell lung cancer (NSCLC) brain metastases treated with stereotactic radiotherapy …

Background Immune checkpoint inhibitors (ICI) have been a breakthrough for selected
cancer patients, including those with brain metastases (BMs). Likewise, steroids have been …

Background Lung cancer is the leading cause of cancer-related death worldwide, with non-
small cell lung cancer (NSCLC) accounting for most cases. While radiotherapy has …

Objectives To compare the incidence of treatment-related necrosis between combination
SRS+ ICI therapy and SRS therapy alone in patients with brain metastases from melanoma …